Suppr超能文献

醛糖还原酶与非酶糖基化在糖尿病大鼠糖性白内障形成中的相对重要性

Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.

作者信息

Kador P F, Lee J W, Fujisawa S, Blessing K, Lou M F

机构信息

Laboratory of Ocular Therapeutics, National Eye Institute, NIH, Bethesda, Maryland 20892-1850, USA.

出版信息

J Ocul Pharmacol Ther. 2000 Apr;16(2):149-60. doi: 10.1089/jop.2000.16.149.

Abstract

The relative importance of sorbitol formation versus nonenzymatic glycosylation and advanced glycosylation end products (AGEs) on sugar cataract formation was examined in diabetic rats. Diabetes was experimentally induced in young, 50 g rats with streptozotocin, and aldose reductase inhibitors were administered in the diet for up to 8 weeks at concentrations of 0.06% for tolrestat or ponalrestat and 0.0125% for AL-1576. Cataract formation was monitored by hand-held slit lamp for up to 11 weeks. Lens polyol levels were monitored by GLC, glycosylated protein levels were spectrophotometrically determined, and AGE products were estimated by fluorescence measurements and ELISA. Sugar cataract formation was observed in all untreated diabetic rats while cataract formation was inhibited in all diabetic rats treated with the AR inhibitors. Lens sorbitol levels were reduced in all ARI-treated rats. Glycosylated lens protein levels were elevated in the diabetic rats, and these levels were not significantly lower in the non-cataractous lenses from ARI-treated diabetic rats. Fluorescence measurements of the lens proteins revealed increased lens AGE levels in all diabetic rats, and these were slightly reduced in the aldose reductase inhibitor treated diabetics. With ELISA, immunoreactive AGEs were only detected in cataractous lenses from the untreated diabetic rats. Immunoreactive AGEs were not detected in the clear lenses of the aldose reductase inhibitor treated diabetics or in the non-diabetic controls. These results support the concept that sugar cataract formation is initiated by the aldose reductase catalyzed intracellular accumulation of polyols and that these sugar cataracts can be prevented through inhibition of aldose reductase.

摘要

在糖尿病大鼠中,研究了山梨醇形成与非酶糖基化及晚期糖基化终产物(AGEs)在糖性白内障形成过程中的相对重要性。通过链脲佐菌素在50克的年轻大鼠中实验性诱导糖尿病,在饮食中给予醛糖还原酶抑制剂,托瑞司他或泊那司他浓度为0.06%,AL - 1576浓度为0.0125%,持续8周。使用手持裂隙灯监测白内障形成长达11周。通过气相色谱法监测晶状体多元醇水平,用分光光度法测定糖基化蛋白水平,通过荧光测量和酶联免疫吸附测定法估算AGE产物。在所有未治疗的糖尿病大鼠中观察到糖性白内障形成,而在用AR抑制剂治疗的所有糖尿病大鼠中白内障形成受到抑制。在所有接受ARI治疗的大鼠中晶状体山梨醇水平降低。糖尿病大鼠中糖基化晶状体蛋白水平升高,在接受ARI治疗的糖尿病大鼠的非白内障晶状体中这些水平没有显著降低。晶状体蛋白的荧光测量显示所有糖尿病大鼠晶状体AGE水平升高,在接受醛糖还原酶抑制剂治疗的糖尿病大鼠中这些水平略有降低。通过酶联免疫吸附测定法,仅在未治疗的糖尿病大鼠的白内障晶状体中检测到免疫反应性AGEs。在接受醛糖还原酶抑制剂治疗的糖尿病大鼠的透明晶状体或非糖尿病对照中未检测到免疫反应性AGEs。这些结果支持了这样的概念,即糖性白内障的形成是由醛糖还原酶催化的细胞内多元醇积累引发的,并且通过抑制醛糖还原酶可以预防这些糖性白内障。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验